Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury

被引:146
作者
Akassoglou, K
Kombrinck, KW
Degen, JL
Strickland, S [1 ]
机构
[1] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA
[2] Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA
关键词
coagulation; extracellular matrix; ancrod; Schwann cells; proteolysis;
D O I
10.1083/jcb.149.5.1157
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tissue plasminogen activator (tPA) is a serine protease that converts plasminogen to plasmin and can trigger the degradation of extracellular matrix: proteins, In the nervous system, under noninflammatory conditions, tPA contributes to excitotoxic neuronal death, probably through degradation of laminin. To evaluate the contribution of extracellular proteolysis in inflammatory neuronal degeneration, we performed sciatic nerve injury in mice. Proteolytic activity was increased in the nerve after injury, and this activity was primarily because of Schwann cell-produced tPA, To identify whether tPA release after nerve damage played a beneficial or deleterious role, we crushed the sciatic nerve of mice deficient for tPA, Axonal demyelination was exacerbated in the absence of tPA or plasminogen, indicating that tPA has a protective role in nerve injury, and that this protective effect is due to its proteolytic action on plasminogen. Axonal damage was correlated with increased fibrin(ogen) deposition, suggesting that this protein might play a role in neuronal injury. Consistent with this idea, the increased axonal degeneration phenotype in tPA- or plasminogen-deficient mice was ameliorated by genetic or pharmacological depletion of fibrinogen, identifying fibrin as the plasmin substrate in the nervous system under inflammatory axonal damage. This study shows that fibrin deposition exacerbates axonal injury, and that induction of an extracellular proteolytic cascade is a beneficial response of the tissue to remove fibrin, tPA/plasmin-mediated fibrinolysis may be a widespread protective mechanism in neuroinflammatory pathologies.
引用
收藏
页码:1157 / 1166
页数:10
相关论文
共 60 条
[1]  
Akassoglou K, 1997, J IMMUNOL, V158, P438
[2]   Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice - Models for multiple sclerosis with primary oligodendrogliopathy [J].
Akassoglou, K ;
Bauer, J ;
Kassiotis, G ;
Pasparakis, M ;
Lassmann, H ;
Kollias, G ;
Probert, L .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :801-813
[3]   Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease [J].
Akenami, FOT ;
Koskiniemi, M ;
Farkkila, M ;
Vaheri, A .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (02) :157-160
[4]   Tissue plasminogen activator gene expression in multiple sclerosis brain tissue [J].
Akenami, FOT ;
Sirén, V ;
Wessman, M ;
Koskiniemi, M ;
Vaheri, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 165 (01) :71-76
[5]   Magnetic resonance spectroscopy: imaging axonal damage in MS [J].
Arnold, DL .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) :2-6
[6]  
BELL WR, 1978, J LAB CLIN MED, V91, P592
[7]   PLASMINOGEN ACTIVATORS IN RAT NEURAL TISSUES DURING DEVELOPMENT AND IN WALLERIAN DEGENERATION [J].
BIGNAMI, A ;
CELLA, G ;
CHI, NH .
ACTA NEUROPATHOLOGICA, 1982, 58 (03) :224-228
[8]   NERVE CRUSH INJURIES - A MODEL FOR AXONOTMESIS [J].
BRIDGE, PM ;
BALL, DJ ;
MACKINNON, SE ;
NAKAO, Y ;
BRANDT, K ;
HUNTER, DA ;
HERTL, C .
EXPERIMENTAL NEUROLOGY, 1994, 127 (02) :284-290
[9]   PLASMINOGEN DEFICIENCY CAUSES SEVERE THROMBOSIS BUT IS COMPATIBLE WITH DEVELOPMENT AND REPRODUCTION [J].
BUGGE, TH ;
FLICK, MJ ;
DAUGHERTY, CC ;
DEGEN, JL .
GENES & DEVELOPMENT, 1995, 9 (07) :794-807
[10]   Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency [J].
Bugge, TH ;
Kombrinck, KW ;
Flick, MJ ;
Daugherty, CC ;
Danton, MJS ;
Degen, JL .
CELL, 1996, 87 (04) :709-719